
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Genekam is to take part in one more project called Fibrogelnet under FP7-PEOPLE-2012-2012 from EU to work on network for development of nanosolutions for nanomedicine. The overall scoring of this project was excellent during evaluation.